EP0682783B1 - Radiographic assemblage - Google Patents

Radiographic assemblage Download PDF

Info

Publication number
EP0682783B1
EP0682783B1 EP95902088A EP95902088A EP0682783B1 EP 0682783 B1 EP0682783 B1 EP 0682783B1 EP 95902088 A EP95902088 A EP 95902088A EP 95902088 A EP95902088 A EP 95902088A EP 0682783 B1 EP0682783 B1 EP 0682783B1
Authority
EP
European Patent Office
Prior art keywords
radiographic
assemblage
tabular
silver halide
grains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP95902088A
Other languages
German (de)
French (fr)
Other versions
EP0682783A1 (en
Inventor
Gérard A. D. Kodak-Pathé FRIOUR
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kodak Pathe SA
Eastman Kodak Co
Original Assignee
Kodak Pathe SA
Eastman Kodak Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kodak Pathe SA, Eastman Kodak Co filed Critical Kodak Pathe SA
Publication of EP0682783A1 publication Critical patent/EP0682783A1/en
Application granted granted Critical
Publication of EP0682783B1 publication Critical patent/EP0682783B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03CPHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
    • G03C5/00Photographic processes or agents therefor; Regeneration of such processing agents
    • G03C5/16X-ray, infrared, or ultraviolet ray processes
    • G03C5/17X-ray, infrared, or ultraviolet ray processes using screens to intensify X-ray images

Definitions

  • the present invention concerns a radiographic assemblage comprising at least one X-ray intensifying screen and a radiographic film which is sensitive to actinic radiation. Such an assemblage enables very high quality radiographs to be obtained, even when a fast processing method is used.
  • radiographic assemblages which comprise an intensifying screen and a photographic film consisting of a support covered on at least one of its two faces with a layer of silver halide emulsion.
  • intensifying screens makes it possible to reduce the quantity of X-rays necessary to obtain a radiograph and consequently to reduce the quantity of X-rays absorbed by the patient.
  • intensifying screens absorb the X-rays and re-emit electromagnetic radiation with a longer wavelength, the modulation of which is registered by the silver halide grains forming the radiographic emulsion.
  • US patent 4 639 411 describes a radiographic film which comprises an emulsion consisting of tabular silver halide grains and able to form a latent image when it is exposed to blue light.
  • This emulsion preferably consists of tabular grains with a thickness of less than 0.5 ⁇ m and an aspect ratio greater than 5:1.
  • sensitising dyes are adsorbed on the surface of the grains.
  • the radiographic film also comprises, interposed between the support and the layer of emulsion, a layer of silver iodide emulsion which absorbs blue light.
  • Such a radiographic film makes it possible to reduce the loss of sharpness due to the diffusion of the light through the support (cross-over).
  • Patent application WO 93/01521 describes a radiographic assemblage comprising an intensifying screen which emits in the ultraviolet wavelengths associated with a special radiographic film.
  • These radiographic films consist of emulsions in which the proportion of chloride in the silver halide grains is at least equal to 50% molar and/or the silver halide grains are tabular grains with a thickness of less than 0.5 ⁇ m and preferably between 0.21 and 0.30 ⁇ m, and a mean aspect ratio greater than 2:1 and preferably between 4.0 and 5.5:1.
  • the intensifying screens associated with these radiographic films comprise a support covered with a layer of luminophores with an emission peak between 300 and 390 nm.
  • Such a radiographic assemblage enables good sensitivity and good image quality to be obtained even for a low exposure to X-rays.
  • the tanning level of the emulsions has a strong influence on the development of the silver, in particular with non-tabular silver halide grains.
  • non-tabular silver halide grains referred to in the remainder of the application as "three-dimensional grains"
  • the covering power of these grains after development is very limited, which causes the sensitivity of the radiographic films to be greatly decreased.
  • the object of the invention is a Screen/Film radiographic assemblage which can be used with a fast processing method and which has an improved sensitometric performance as well as good image quality.
  • the radiographic assemblage of the invention comprises (a) an X-ray reinforcing screen which emits mainly ultraviolet radiation and (b), associated with this screen, a photosensitive film comprising a tabular-grain silver halide emulsion.
  • This radiographic system may be developed by fast processing methods.
  • Ultraviolet radiation (referred to hereinafter as “ultraviolet”) is defined as the electromagnetic radiation with a wavelength between that of violet light and that of X-rays.
  • the radiographic assemblage of the invention comprises at least one X-ray intensifying screen and a radiographic film consisting of a support covered on at least one of its faces with a silver halide emulsion and is characterised in that at least 50% of the silver halide grains of the emulsion are tabular grains with an average thickness of less than 0.5 ⁇ m and preferably less than 0.2 ⁇ m, and an aspect ratio (R) between 5 and 25 and preferably between 10 and 20, and the X-ray intensifying screen comprises a support covered with a fluorescent layer comprising dispersed in a binder, a luminophore with a maximum emission as close as possible to the intrinsic sensitivity peak of the silver halide grains forming the radiographic film.
  • the aspect ratio (R) is the ratio of the equivalent circular diameter (ECD) to the average thickness of the tabular grains (e).
  • the emulsions used in the assemblage of the invention consist of grains of silver chloride, silver bromide, silver iodide or a mixture of these halides, in a binder.
  • the binder is a water-permeable hydrophilic colloid such as gelatin, gelatin derivatives, albumin, polyvinyl alcohol, polyvinyl polymers, etc.
  • emulsions can be prepared in accordance with the precipitation techniques described in US patents 4.425.425 or 4.425.426.
  • monodisperse emulsions are used.
  • the monodispersity of the emulsion is defined from the coefficient of variation (COV) which, expressed as a percentage, is equal to ( ⁇ /ECD).100.
  • the preferred monodisperse emulsions have a COV of less than 20% and preferably below 10%.
  • These monodisperse tabular- grain emulsions can be prepared in accordance with the method described in US patent 5.210.013.
  • the emulsions used in the assemblage of the invention can be tanned in accordance with one of the methods described in US patent 4.425.426.
  • the tanning agents which can be used are described in Research Disclosure , December 1989, No 308113, Section X.
  • the emulsions may contain other compounds such as anti-fogging agents, stabilisers or antistatic agents.
  • the radiographic film may comprise a top layer containing matting agents. This top layer or the sensitive layer may contain plasticisers or lubricants. These compounds were described in Research Disclosure , Vol 184, August 1979, No 18431.
  • silver halide emulsions used in the assemblage of the invention are preferably chemically sensitised by means of sulphur and/or gold and/or selenium, in accordance with the conventional chemical sensitisation methods described in Research Disclosure , December 1989, No 308119, Section III.
  • the emulsions used in the assemblage of the invention may be spectrally sensitised.
  • the conventional spectral sensitisation methods which can be used within the scope of the invention are described in Research Disclosure , December 1989, No 308119, Section IV.
  • the maximum intrinsic sensitivity of the tabular silver halide grains is, surprisingly, situated in the ultraviolet range; this sensitivity peak in the ultraviolet range is specific to tabular grains; it is not observed in non-tabular silver halide grains.
  • the intensity of the sensitivity peak varies with the aspect ratio of the tabular grains.
  • the presence of such a sensitivity peak makes it possible to explain why tabular- grain emulsions have a sensitivity greater than or equal to that of three-dimensional grains, independently of the presence of spectral sensitising dyes (Fig 2).
  • radiographic films used in the assemblage of the invention are therefore obtained in a smaller number of stages.
  • the films used in the assemblage of the invention can be developed using conventional development processes.
  • radiographic films used in the assemblage of the invention are totally compatible with fast processing methods. Indeed, emulsions consisting of tabular grains with a high aspect ratio may be highly tanned without any impairment of their covering power being observed.
  • the photographic film consists of a support able to transmit ultraviolet.
  • Such a support may adsorb part of the ultraviolet passing through it. This adsorption of the support enables the cross-over to be reduced without having recourse to the additives commonly used for this purpose.
  • a support made of a polyester such as polyethylene terephthalate can be used.
  • the support is covered on at least one face, and preferably on both faces, with a silver halide emulsion with grains with a high aspect ratio according to the invention.
  • the two faces of the supports may carry layers of identical or different emulsions.
  • the X-ray intensifying screen used in the assemblage of the invention comprises a support covered with a fluorescent layer comprising, dispersed in a binder, a luminophore having a maximum emission between 300 and 390 nm.
  • the X-ray intensifying screen used in the assemblage of the invention comprises one or more luminophores mixed in a binder.
  • the luminophore or luminophores used have a maximum emission in the ultraviolet. This maximum emission must be as close as possible to the intrinsic sensitivity peak of the silver halide grains forming the radiographic film.
  • the luminophores which emit in the ultraviolet are, for example, thallium oxides such as YTaO 4 , which may be activated by gadolinium, bismuth, lead or cerium atoms, or a mixture of these activators, the oxides of lanthane La 2 O 2 S or LaOBr, whether activated or not.
  • the luminophores may consist of zirconium germanate and hafnium germanate crystals with a tetragonal scheelite structure and containing no titanium, as described in European patent application 552116.
  • luminophores may be used alone or in a mixture.
  • the luminophores used in the assemblage of the invention have an emission peak between 300 and 390 nm and preferably between 310 and 360 nm.
  • the X-ray intensifying screens comprise a support covered with a fluorescent layer containing the luminophore or luminophores in the form of particles in a mixture in a binder.
  • the size of the particles of the luminophores is generally between 0.5 and 10 ⁇ m and preferably between 1 and 20 ⁇ m.
  • the useful binders are chosen from organic polymers transparent to ultraviolet and to X-rays, such as vinyl alcohol and o-sulphobenzaldehyde acetal polymers, chlorosulphonated polyethylenes, bisphenol polycarbonates, copolymers of alkyl acrylate and methacrylate, or polyurethanes.
  • organic polymers transparent to ultraviolet and to X-rays such as vinyl alcohol and o-sulphobenzaldehyde acetal polymers, chlorosulphonated polyethylenes, bisphenol polycarbonates, copolymers of alkyl acrylate and methacrylate, or polyurethanes.
  • Other binders which can be used within the scope of the invention are described in US patents 2.502.529, 2.887.379, 3.617.285, 3.300.310, 3.300.311 and 3.743.833 and in Research Disclosure , Vol 154, February 1977.
  • the preferred binders are polyurethanes such as Estane®, Permuthane® and Car
  • the X-ray intensifying screen may contain, in addition to the fluorescent layer, a protective layer and a reflective layer.
  • the radiographic assemblage of the invention comprises in general terms a pair of X-ray intensifying screens situated on each side of the radiographic film.
  • Such a radiographic assemblage makes it possible inter alia to expose the patient to smaller quantities of X-rays.
  • the present invention is illustrated by the following examples which show the sensitometric advantages of the invention in comparison with conventional radiographic assemblages.
  • the films used in the assemblage of the invention described in the following examples consist of an ESTAR® support covered, in this order, with a layer of silver bromide emulsion (21 mg/dm 2 ) and a top layer of gelatin (6.88 mg/dm 2 ).
  • the film is tanned by means of bis (vinylsulphonylmethyl) ether, the content by weight of tanning agent being equal to 2.25% of the total dry gelatin contained in the film.
  • These emulsions are monodisperse (COV of less than 10%) and chemically sensitised optimally by means of sulphur and gold, the quantity of sulphur being between 15,000 and 25,000 At/ ⁇ m 2 and the quantity of gold between 7,500 and 12,500 At/ ⁇ m 2 .
  • the tabular silver bromide grains represent more than 90% of the total number of grains forming the emulsion.
  • the films consisting of tabular-grain emulsions have a sensitivity peak which does not appear with the X-OMAT-S® commercial film consisting of a three-dimensional grain emulsion. Consequently the sensitivity peak is not related to the chromatisation of the tabular emulsion.
  • Figure 2 shows that the sensitivity peak varies with the aspect ratio of the tabular grains.
  • Figure 3 shows the photographic sensitivity of these films when they are exposed to visible radiation (430 nm) and when they are exposed to ultraviolet radiation (330 nm).
  • This figure shows the considerable gain in photographic sensitivity obtained with the films used in the assemblage of the present invention exposed to ultraviolet radiation.
  • the top layer and intermediate layer consist of gelatin (each 3.54 mg/dm 2 ).
  • the emulsion layer consists of gelatin (32 mg/dm 2 ) and silver halides (21 mg/dm 2 ).
  • the film is tanned by means of the compound bis (vinylsulphonylmethyl) ether, the content by weight of tanning agent being equal to 2.35% of the total dry gelatin contained in the film.
  • the emulsions in the films are chemically and spectrally sensitised optimally in accordance with the methods described above.
  • the exposures were made on a medical radiography table with a SIEMENS POLYDOROS 100® generator equipped with an OPTILIX 150/40/102G® tube with a tungsten rotating anode.
  • the filtration is 2.5 mm of aluminium.
  • the generator operates at 70 kV and between 30 and 40 mA.
  • the films used in the assemblage of the invention may advantageously be processed either using a conventional processing method or a fast processing method, which is not possible with a conventional radiographic film.
  • the films are exposed between two X-ray intensifying screens, either the X-OMAT-Regular® screen (emission peak 380 nm) consisting of barium sulphate with europium added, or a screen which emits in the ultraviolet wavelengths consisting of germanium oxide and hafnium oxide, the emission of this screen being centred on 340 nm.
  • X-OMAT-Regular® screen emission peak 380 nm
  • a screen which emits in the ultraviolet wavelengths consisting of germanium oxide and hafnium oxide the emission of this screen being centred on 340 nm.
  • the films are developed using an RP X-OMAT MX810® process, at 35°C.
  • the sensitometric results obtained with the X-ray intensifying screen emitting in the ultraviolet range are set out in the following table: REFERENCE FOGGING RELATIVE SPEED CONTRAST X-OMAT-S® 0.23 100 3.07 X-OMAT-K® 0.22 85 2.60 INVENTION 1 0.23 99 2.76 INVENTION 2 0.20 100 2.99

Landscapes

  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Conversion Of X-Rays Into Visible Images (AREA)

Description

The present invention concerns a radiographic assemblage comprising at least one X-ray intensifying screen and a radiographic film which is sensitive to actinic radiation. Such an assemblage enables very high quality radiographs to be obtained, even when a fast processing method is used.
In radiography, and particularly in medical radiography, radiographic assemblages are commonly used which comprise an intensifying screen and a photographic film consisting of a support covered on at least one of its two faces with a layer of silver halide emulsion.
The use of intensifying screens makes it possible to reduce the quantity of X-rays necessary to obtain a radiograph and consequently to reduce the quantity of X-rays absorbed by the patient.
These intensifying screens absorb the X-rays and re-emit electromagnetic radiation with a longer wavelength, the modulation of which is registered by the silver halide grains forming the radiographic emulsion.
The use of tabular-grain silver halide emulsions in radiographic products is known.
For example, US patent 4 639 411 describes a radiographic film which comprises an emulsion consisting of tabular silver halide grains and able to form a latent image when it is exposed to blue light. This emulsion preferably consists of tabular grains with a thickness of less than 0.5 µm and an aspect ratio greater than 5:1.
In order to optimise the absorption of blue light by the silver halide grains, sensitising dyes are adsorbed on the surface of the grains.
The radiographic film also comprises, interposed between the support and the layer of emulsion, a layer of silver iodide emulsion which absorbs blue light.
Such a radiographic film makes it possible to reduce the loss of sharpness due to the diffusion of the light through the support (cross-over).
Patent application WO 93/01521 describes a radiographic assemblage comprising an intensifying screen which emits in the ultraviolet wavelengths associated with a special radiographic film. These radiographic films consist of emulsions in which the proportion of chloride in the silver halide grains is at least equal to 50% molar and/or the silver halide grains are tabular grains with a thickness of less than 0.5 µm and preferably between 0.21 and 0.30 µm, and a mean aspect ratio greater than 2:1 and preferably between 4.0 and 5.5:1.
The examples in patent application WO 93/01521 describe a tabular-grain silver bromoiodide emulsion with a thickness of 0.2 µm and an aspect ratio of 5:1.
The intensifying screens associated with these radiographic films comprise a support covered with a layer of luminophores with an emission peak between 300 and 390 nm.
Such a radiographic assemblage enables good sensitivity and good image quality to be obtained even for a low exposure to X-rays.
In parallel to the development of more efficient radiographic assemblages, attempts are being made to process radiographic films by faster methods. The length of a traditional fast processing method is around 90 seconds; the length of the most efficient processing methods is around 45 seconds.
These fast processing methods are generally not very compatible with conventional radiographic films.
It is necessary to avoid water retention during the development, fixing and washing stages and to avoid physical defects which appear during drying. Consequently, the stage which limits a fast processing method is the film drying stage. This is why films intended to be processed in this way must be highly tanned.
The tanning level of the emulsions has a strong influence on the development of the silver, in particular with non-tabular silver halide grains. For example, when emulsions with non-tabular grains (referred to in the remainder of the application as "three-dimensional grains") are highly tanned, the covering power of these grains after development is very limited, which causes the sensitivity of the radiographic films to be greatly decreased.
It is therefore very useful to develop a radiographic assemblage which can be used in fast processing methods and which makes it possible to obtain quality radiographs with a low level of exposure to X-rays.
As is shown by the prior art cited above, the use of tabular-grain emulsions in radiographic assemblages is known. However, none of the known systems has the sensitometric advantages of the present invention.
The object of the invention is a Screen/Film radiographic assemblage which can be used with a fast processing method and which has an improved sensitometric performance as well as good image quality.
  • Figures 1 and 2 show the intrinsic sensitivity of grains with different morphologies as a function of the exposure wavelength.
  • Figure 3 shows the performance of the assemblage of the present invention in comparison with the known conventional assemblage.
  • The radiographic assemblage of the invention comprises (a) an X-ray reinforcing screen which emits mainly ultraviolet radiation and (b), associated with this screen, a photosensitive film comprising a tabular-grain silver halide emulsion. This radiographic system may be developed by fast processing methods.
    Ultraviolet radiation (referred to hereinafter as "ultraviolet") is defined as the electromagnetic radiation with a wavelength between that of violet light and that of X-rays.
    The radiographic assemblage of the invention comprises at least one X-ray intensifying screen and a radiographic film consisting of a support covered on at least one of its faces with a silver halide emulsion and is characterised in that at least 50% of the silver halide grains of the emulsion are tabular grains with an average thickness of less than 0.5 µm and preferably less than 0.2 µm, and an aspect ratio (R) between 5 and 25 and preferably between 10 and 20, and the X-ray intensifying screen comprises a support covered with a fluorescent layer comprising dispersed in a binder, a luminophore with a maximum emission as close as possible to the intrinsic sensitivity peak of the silver halide grains forming the radiographic film.
    The aspect ratio (R) is the ratio of the equivalent circular diameter (ECD) to the average thickness of the tabular grains (e).
    The emulsions used in the assemblage of the invention consist of grains of silver chloride, silver bromide, silver iodide or a mixture of these halides, in a binder.
    The binder is a water-permeable hydrophilic colloid such as gelatin, gelatin derivatives, albumin, polyvinyl alcohol, polyvinyl polymers, etc.
    These emulsions can be prepared in accordance with the precipitation techniques described in US patents 4.425.425 or 4.425.426.
    According to one embodiment, monodisperse emulsions are used. The monodispersity of the emulsion is defined from the coefficient of variation (COV) which, expressed as a percentage, is equal to (σ/ECD).100.
    The preferred monodisperse emulsions have a COV of less than 20% and preferably below 10%. These monodisperse tabular- grain emulsions can be prepared in accordance with the method described in US patent 5.210.013.
    The emulsions used in the assemblage of the invention can be tanned in accordance with one of the methods described in US patent 4.425.426. The tanning agents which can be used are described in Research Disclosure, December 1989, No 308113, Section X.
    In addition to the characteristics specifically described above, the emulsions may contain other compounds such as anti-fogging agents, stabilisers or antistatic agents. The radiographic film may comprise a top layer containing matting agents. This top layer or the sensitive layer may contain plasticisers or lubricants. These compounds were described in Research Disclosure, Vol 184, August 1979, No 18431.
    These silver halide emulsions used in the assemblage of the invention are preferably chemically sensitised by means of sulphur and/or gold and/or selenium, in accordance with the conventional chemical sensitisation methods described in Research Disclosure, December 1989, No 308119, Section III.
    The emulsions used in the assemblage of the invention may be spectrally sensitised. The conventional spectral sensitisation methods which can be used within the scope of the invention are described in Research Disclosure, December 1989, No 308119, Section IV.
    As shown in Figure 1, the maximum intrinsic sensitivity of the tabular silver halide grains is, surprisingly, situated in the ultraviolet range; this sensitivity peak in the ultraviolet range is specific to tabular grains; it is not observed in non-tabular silver halide grains.
    In addition, the intensity of the sensitivity peak varies with the aspect ratio of the tabular grains. The presence of such a sensitivity peak makes it possible to explain why tabular- grain emulsions have a sensitivity greater than or equal to that of three-dimensional grains, independently of the presence of spectral sensitising dyes (Fig 2).
    The radiographic films used in the assemblage of the invention are therefore obtained in a smaller number of stages.
    The films used in the assemblage of the invention can be developed using conventional development processes.
    In addition, the radiographic films used in the assemblage of the invention are totally compatible with fast processing methods. Indeed, emulsions consisting of tabular grains with a high aspect ratio may be highly tanned without any impairment of their covering power being observed.
    In one embodiment of the invention, the photographic film consists of a support able to transmit ultraviolet.
    However, such a support may adsorb part of the ultraviolet passing through it. This adsorption of the support enables the cross-over to be reduced without having recourse to the additives commonly used for this purpose.
    Within the scope of the invention, a support made of a polyester such as polyethylene terephthalate can be used.
    The support is covered on at least one face, and preferably on both faces, with a silver halide emulsion with grains with a high aspect ratio according to the invention. The two faces of the supports may carry layers of identical or different emulsions.
    The X-ray intensifying screen used in the assemblage of the invention comprises a support covered with a fluorescent layer comprising, dispersed in a binder, a luminophore having a maximum emission between 300 and 390 nm.
    The X-ray intensifying screen used in the assemblage of the invention comprises one or more luminophores mixed in a binder. The luminophore or luminophores used have a maximum emission in the ultraviolet. This maximum emission must be as close as possible to the intrinsic sensitivity peak of the silver halide grains forming the radiographic film.
    The luminophores which emit in the ultraviolet are, for example, thallium oxides such as YTaO4, which may be activated by gadolinium, bismuth, lead or cerium atoms, or a mixture of these activators, the oxides of lanthane La2O2S or LaOBr, whether activated or not. The luminophores may consist of zirconium germanate and hafnium germanate crystals with a tetragonal scheelite structure and containing no titanium, as described in European patent application 552116.
    These luminophores may be used alone or in a mixture.
    The luminophores used in the assemblage of the invention have an emission peak between 300 and 390 nm and preferably between 310 and 360 nm.
    The X-ray intensifying screens comprise a support covered with a fluorescent layer containing the luminophore or luminophores in the form of particles in a mixture in a binder. The size of the particles of the luminophores is generally between 0.5 and 10 µm and preferably between 1 and 20 µm.
    The useful binders are chosen from organic polymers transparent to ultraviolet and to X-rays, such as vinyl alcohol and o-sulphobenzaldehyde acetal polymers, chlorosulphonated polyethylenes, bisphenol polycarbonates, copolymers of alkyl acrylate and methacrylate, or polyurethanes. Other binders which can be used within the scope of the invention are described in US patents 2.502.529, 2.887.379, 3.617.285, 3.300.310, 3.300.311 and 3.743.833 and in Research Disclosure, Vol 154, February 1977. The preferred binders are polyurethanes such as Estane®, Permuthane® and Cargill®.
    The X-ray intensifying screen may contain, in addition to the fluorescent layer, a protective layer and a reflective layer.
    The methods of manufacturing the screens and radiographic films are described in the Research Disclosure cited above, No 18431.
    The radiographic assemblage of the invention comprises in general terms a pair of X-ray intensifying screens situated on each side of the radiographic film.
    The combination of a film as described above and an X-ray intensifying screen which emits in the ultraviolet wavelengths enables a radiographic assemblage to be obtained which is more efficient than a conventional system equipped with a screen which does not emit in the ultraviolet wavelengths.
    Such a radiographic assemblage makes it possible inter alia to expose the patient to smaller quantities of X-rays.
    The present invention is illustrated by the following examples which show the sensitometric advantages of the invention in comparison with conventional radiographic assemblages.
    EXAMPLES
    The films used in the assemblage of the invention described in the following examples consist of an ESTAR® support covered, in this order, with a layer of silver bromide emulsion (21 mg/dm2) and a top layer of gelatin (6.88 mg/dm2). The film is tanned by means of bis (vinylsulphonylmethyl) ether, the content by weight of tanning agent being equal to 2.25% of the total dry gelatin contained in the film. These emulsions are monodisperse (COV of less than 10%) and chemically sensitised optimally by means of sulphur and gold, the quantity of sulphur being between 15,000 and 25,000 At/µm2 and the quantity of gold between 7,500 and 12,500 At/µm2.
    The tabular silver bromide grains represent more than 90% of the total number of grains forming the emulsion.
    EXAMPLE 1
    This example is illustrated in Figure 1.
    • Figure (1A) shows the spectral sensitivity curve obtained with X-OMAT-S® film, which consists of a three-dimensional grain emulsion.
    • Figure (1B) shows the spectral sensitivity curve obtained from a tabular silver bromide grain emulsion (ECD = 2.40 µm, e = 0.125 µm, R = 19.2, COV = 6.6) which was sensitised with a blue-sensitive sensitising dye (maximum absorption 440 nm)
    • Figure (1C) shows the spectral sensitivity curve obtained from a tabular silver bromide grain emulsion (ECD = 2.40 µm, e = 0.125 µm, R = 19.2, COV = 6.6) which was not chromatised.
    • Figure (1D) shows the absorption curve of the support.
    It can be seen that in the ultraviolet region the films consisting of tabular-grain emulsions have a sensitivity peak which does not appear with the X-OMAT-S® commercial film consisting of a three-dimensional grain emulsion. Consequently the sensitivity peak is not related to the chromatisation of the tabular emulsion.
    EXAMPLE 2
    This example is illustrated in Figure 2. The various figures are obtained with the emulsions described in the following table:
    REFERENCE E.C.D. µm THICKNESS µm COV % ASPECT RATIO
    2A 2.40 0.125 6.6 19.20
    2B 2.63 0.085 7.6 30.94
    2C 3.12 0.140 3.9 22.29
    2D 1.45 0.60 7.9 2.42
    2E 1.96 0.49 6.2 4.00
    Figure 2 shows that the sensitivity peak varies with the aspect ratio of the tabular grains.
    EXAMPLE 3
    The tabular grain emulsions used in the assemblage of the invention described in the following table were used to produce radiographic films as described in the introductory part of the examples.
    REFERENCE ECD µm THICKNESS µm ASPECT RATIO RELATIVE SPEED AT 330 nm RELATIVE SPEED AT 430 nm
    1 0.85 - 1.00 100 90.2
    2 1.45 0.60 2.42 105.9 48.1
    3 1.96 0.49 4.00 134.3 47.0
    4 2.39 0.30 7.97 185.4 58.5
    5 2.43 0.28 8.68 221.3 62.2
    6 2.69 0.225 11.96 209.4 54.6
    7 2.88 0.23 12.52 225.9 47.8
    8 2.40 0.125 19.20 173.8 45.8
    9 2.82 0.131 21.53 199.1 56.8
    10 3.07 0.142 21.62 131.8 29.2
    11 3.12 0.14 22.29 139.3 34.4
    12 3.65 0.135 27.04 127.6 28.1
    13 2.63 0.085 30.94 92.9 19.4
    Figure 3 shows the photographic sensitivity of these films when they are exposed to visible radiation (430 nm) and when they are exposed to ultraviolet radiation (330 nm).
    This figure shows the considerable gain in photographic sensitivity obtained with the films used in the assemblage of the present invention exposed to ultraviolet radiation.
    EXAMPLE 4
    The following examples describe double-face radiographic films used in the assemblage the invention with the following structure:
    Top layer of gelatin
    Intermediate layer
    Emulsion
    Support
    Emulsion
    Intermediate layer
    Top layer
    The top layer and intermediate layer consist of gelatin (each 3.54 mg/dm2). The emulsion layer consists of gelatin (32 mg/dm2) and silver halides (21 mg/dm2). The film is tanned by means of the compound bis (vinylsulphonylmethyl) ether, the content by weight of tanning agent being equal to 2.35% of the total dry gelatin contained in the film. The emulsions in the films are chemically and spectrally sensitised optimally in accordance with the methods described above.
    In this example, a film was exposed comprising a tabular silver bromide grain emulsion according to the invention (ECD = 2.95 µm, e = 0.16 µm, R = 18.4) and an X-OMAT-K® commercial film (three-dimensional grains) through an X-ray intensifying screen emitting in the ultraviolet range. The exposures were made on a medical radiography table with a SIEMENS POLYDOROS 100® generator equipped with an OPTILIX 150/40/102G® tube with a tungsten rotating anode. The filtration is 2.5 mm of aluminium. The generator operates at 70 kV and between 30 and 40 mA.
    The exposed films are then processed with a conventional development process (X-OMAT-RP® process) and a fast processing method (RA/30®) in accordance with the conditions set out in Table 4 below:
    FILM DEVELOPER DEVELOPMENT TIME SPEED
    X-OMAT-K® X-OMAT-RP® 90 sec 100
    INVENTION X-OMAT-RP® 90 sec 103
    X-OMAT-K® RA/30® 45 sec -
    INVENTION RA/30® 45 sec 100
    X-OMAT-K® RA/30® 60 sec -
    INVENTION RA/30® 60 sec 112
    The results show that the films used in the assemblage of the invention may advantageously be processed either using a conventional processing method or a fast processing method, which is not possible with a conventional radiographic film.
    EXAMPLE 5
    In this example the films used in the assemblage of the invention (with the double-face format described above) have been compared with the X-OMAT-S® and X-OMAT-K® commercial films described below. In this case the exposures were made on an inverse square bench using a SIEFERT ISOVOLT generator equipped with a 160C tube (tungsten anode) at 70 kV. The quality of the beam was that described in ISO 9236.
    REFERENCE TYPE OF GRAIN E.C.D. µm THICKNESS µm
    X-OMAT-S® 3D - -
    X-OMAT-K® 3D - -
    INVENTION 1 Tabular 2.95 0.16
    INVENTION 2 Tabular 2.98 0.13
    The films are exposed between two X-ray intensifying screens, either the X-OMAT-Regular® screen (emission peak 380 nm) consisting of barium sulphate with europium added, or a screen which emits in the ultraviolet wavelengths consisting of germanium oxide and hafnium oxide, the emission of this screen being centred on 340 nm.
    After exposure, the films are developed using an RP X-OMAT MX810® process, at 35°C.
    The sensitometric results obtained with the X-OMATIC Regular® screen are set out in the following table:
    REFERENCE FOGGING RELATIVE SPEED CONTRAST
    X-OMAT-S® 0.23 100 3.05
    X-OMAT-K® 0.22 86 2.61
    INVENTION 1 0.23 87 .01
    INVENTION 2 0.20 88 3.27
    The sensitometric results obtained with the X-ray intensifying screen emitting in the ultraviolet range are set out in the following table:
    REFERENCE FOGGING RELATIVE SPEED CONTRAST
    X-OMAT-S® 0.23 100 3.07
    X-OMAT-K® 0.22 85 2.60
    INVENTION 1 0.23 99 2.76
    INVENTION 2 0.20 100 2.99
    These results show the sensitometric performance of the radiographic assemblages of the present invention.

    Claims (7)

    1. Radiographic assemblage comprising at least one X-ray intensifying screen and a radiographic film consisting of a support with a layer of silver halide emulsion on at least one of its faces, characterised in that at least 50% of the silver halide emulsion consists of tabular grains with a thickness of less than 0.5 µm and an aspect ratio between 5 and 25, and the X-ray intensifying screen comprises a support covered with a fluorescent layer comprising, dispersed in a binder, a luminophore with a maximum emission as close as possible to the intrinsic sensitivity peak of the silver halide grains forming the radiographic film.
    2. Radiographic assemblage according to claim 1, in which the thickness of the tabular grains is less than 0.2 µm and the aspect ratio is between 10 and 20.
    3. Radiographic assemblage according to Claim 2, in which at least 90% of the silver halide grains are tabular.
    4. Radiographic assemblage according to Claim 1, in which the X-ray intensifying screen consists of one or more luminophores in the form of particles in a mixture in a binder transparent to ultraviolet and X-rays.
    5. Radiographic assemblage according to claim 4, in which the luminophore or luminophores have a maximum emission between 310 and 350 nm.
    6. Radiographic assemblage according to any one of the preceding claims, in which the X-ray intensifying screen consists of particles of germanium oxide and hafnium oxide.
    7. Use of a radiographic assemblage according to any one of the preceding claims in a fast processing method.
    EP95902088A 1993-12-02 1994-11-25 Radiographic assemblage Expired - Lifetime EP0682783B1 (en)

    Applications Claiming Priority (3)

    Application Number Priority Date Filing Date Title
    FR9314680 1993-12-02
    FR9314680A FR2713355B1 (en) 1993-12-02 1993-12-02 Radiographic system.
    PCT/EP1994/003908 WO1995015514A1 (en) 1993-12-02 1994-11-25 Radiographic system

    Publications (2)

    Publication Number Publication Date
    EP0682783A1 EP0682783A1 (en) 1995-11-22
    EP0682783B1 true EP0682783B1 (en) 2000-08-16

    Family

    ID=9453665

    Family Applications (1)

    Application Number Title Priority Date Filing Date
    EP95902088A Expired - Lifetime EP0682783B1 (en) 1993-12-02 1994-11-25 Radiographic assemblage

    Country Status (4)

    Country Link
    EP (1) EP0682783B1 (en)
    DE (1) DE69425558T2 (en)
    FR (1) FR2713355B1 (en)
    WO (1) WO1995015514A1 (en)

    Family Cites Families (3)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    JPH03210553A (en) * 1990-01-16 1991-09-13 Fuji Photo Film Co Ltd Silver halide photographic sensitive material
    US5252442A (en) * 1991-05-14 1993-10-12 Eastman Kodak Company Radiographic elements with improved detective quantum efficiencies
    US5173611A (en) * 1992-01-17 1992-12-22 Eastman Kodak Company Phosphor composition and X-ray intensifying screen exhibiting peak emission in the ultraviolet

    Also Published As

    Publication number Publication date
    FR2713355B1 (en) 1996-05-03
    EP0682783A1 (en) 1995-11-22
    DE69425558T2 (en) 2001-05-23
    WO1995015514A1 (en) 1995-06-08
    FR2713355A1 (en) 1995-06-09
    DE69425558D1 (en) 2000-09-21

    Similar Documents

    Publication Publication Date Title
    EP0595733B1 (en) Imaging combination for detecting soft tissue anomalies
    EP0028521B1 (en) Green-emitting x-ray intensifying screens
    CA1321095C (en) Unitary intensifying screen and radiographic element
    EP0276497B1 (en) Process for the production of multiple radiographic images
    EP1223464A2 (en) Light-weight imaging assemblies for oncology portal imaging
    US5952147A (en) Portal verification radiographic element and method of imaging
    EP1462857B1 (en) Radiographic imaging assembly with blue-sensitive film
    EP0682783B1 (en) Radiographic assemblage
    EP0627744B1 (en) Improved radiological system employing phospors of different densities
    EP0237335A2 (en) Radiographic elements exhibiting reduced crossover
    JPH10171049A (en) Silver halide photographic sensitive material, and photographic composition using the same
    EP1422561B1 (en) Radiographic imaging assembly for mammography
    EP0710879B1 (en) Radiographic product
    US6815155B2 (en) Radiographic imaging system and silver halide photographic material
    EP0592616B1 (en) Ultraviolet film/screen combinations for improved radiological evaluations
    JP2583417B2 (en) Radiation image forming method
    US6828077B2 (en) Mammography imaging method using high peak voltage
    EP1422557B1 (en) Mammography film and imaging assembly for use with rhodium or tungsten anodes
    WO1993001522A1 (en) Single screen/film structure with greatly improved radiological properties
    Debelder et al. Intensifying screens in transaxial tomography
    CA2143694A1 (en) Method of autoradiographic imaging
    JP2001242573A (en) Silver halide photographic sensitive material, photographic assembly using the same and x-ray image forming system
    GB2056112A (en) Intensifying Screens in Transaxial Tomography
    JPH1062881A (en) Silver halide photographic sensitive material and photographic system using it
    JPH11109564A (en) Silver halide photographic sensitive material and photographic assembly using the same

    Legal Events

    Date Code Title Description
    PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

    Free format text: ORIGINAL CODE: 0009012

    17P Request for examination filed

    Effective date: 19950817

    AK Designated contracting states

    Kind code of ref document: A1

    Designated state(s): DE FR GB

    17Q First examination report despatched

    Effective date: 19990119

    RTI1 Title (correction)

    Free format text: RADIOGRAPHIC ASSEMBLAGE

    GRAG Despatch of communication of intention to grant

    Free format text: ORIGINAL CODE: EPIDOS AGRA

    GRAG Despatch of communication of intention to grant

    Free format text: ORIGINAL CODE: EPIDOS AGRA

    GRAH Despatch of communication of intention to grant a patent

    Free format text: ORIGINAL CODE: EPIDOS IGRA

    GRAH Despatch of communication of intention to grant a patent

    Free format text: ORIGINAL CODE: EPIDOS IGRA

    GRAA (expected) grant

    Free format text: ORIGINAL CODE: 0009210

    AK Designated contracting states

    Kind code of ref document: B1

    Designated state(s): DE FR GB

    REF Corresponds to:

    Ref document number: 69425558

    Country of ref document: DE

    Date of ref document: 20000921

    RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

    Owner name: EASTMAN KODAK COMPANY

    Owner name: KODAK-PATHE

    ET Fr: translation filed
    REG Reference to a national code

    Ref country code: FR

    Ref legal event code: TP

    PLBE No opposition filed within time limit

    Free format text: ORIGINAL CODE: 0009261

    STAA Information on the status of an ep patent application or granted ep patent

    Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

    26N No opposition filed
    REG Reference to a national code

    Ref country code: GB

    Ref legal event code: IF02

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: GB

    Payment date: 20031002

    Year of fee payment: 10

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: FR

    Payment date: 20031105

    Year of fee payment: 10

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: GB

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20041125

    GBPC Gb: european patent ceased through non-payment of renewal fee

    Effective date: 20041125

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: FR

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20050729

    REG Reference to a national code

    Ref country code: FR

    Ref legal event code: ST

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: DE

    Payment date: 20061130

    Year of fee payment: 13

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: DE

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20080603